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Abstract
Extensive clinical research has provided robust evidence that exercise is a cost-
effective measure to substantially alleviate the burden of a large number of diseases,
many of which belong to the cardiovascular (CV) spectrum. In terms of cardiac bene-
fit, the positive effects of exercise are attributed to improvements in standard risk
factors for atherosclerosis, as well as to its positive impact on several pathophysio-
logical mechanisms for CV diseases. For secondary prevention, exercise, optimally in
the context of a cardiac rehabilitation program, has been shown to improve func-
tional capacity and survival. Clinicians should encourage physical activity and provide
exercise recommendations for all patients, taking into consideration any underlying
pathology. In the present review, the benefits of exercise for the prevention and
treatment of major CV risk factors and heart conditions are analyzed.
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1 | INTRODUCTION
The notion that exercise is important for well-being, health, and lon-
gevity has been documented throughout history and all over the
world.1 Susruta, an Indian physician who lived during 600 Before
Common Era (BCE) was the first healer who prescribed exercise and
advised that the regimen should be performed daily and be of half
the extent of the patient's capacity. Hippocrates (460-370 BCE)
identified the joined importance of food and exercise and was the
first physician to prescribe exercise in written form for a patient
“suffering from consumption.” Bernardino Ramazzini, the father of
occupational medicine, noted that professional messengers were
generally healthier compared to those with sedentary jobs such as
tailors. Since the seminal studies from the 1950s, a burgeoning
amount of evidence has accumulated, supporting exercise as a
highly cost-effective measure for the prevention and treatment of
disease. Currently, exercise has been shown to be capable of
preventing over 35 chronic conditions, many of which are within
the cardiovascular (CV) spectrum, as well as of reducing CV and all-
cause mortality.2
Despite the world-wide strategies to promote sufficient physical
activity (PA) at a population level, adoption rates of a physically active
lifestyle have been far from ideal. It is estimated that one in five adults
lack acceptable PA and that only half the population in developed
countries follow the widely applied recommendation of a minimum of
150 minutes of moderate-intensity exercise weekly.3
Physical inactivity is a principal contributor to the global burden
of disease. Calculations of population-attributable fractions have
shown that PA not meeting current recommendations is the cause of
6% of the burden of coronary artery disease (CAD), 7% of type 2 dia-
betes mellitus (T2DM), and 9% of premature death.4 Exercise may
protect against certain cancers such as breast, colon, prostate, and
pancreatic cancer. It also reduces rates of osteoporosis and hip frac-
tures, dementia, anxiety and depression. The importance of exercise
for CV protection is supported by mostly epidemiological data in the
setting of primary prevention and randomized clinical study data in
the setting of secondary prevention.5 In the present article, the cur-
rent evidence of the associations of exercise with CV outcome will be
reviewed. The benefits of exercise for the prevention and treatment
of major CV risk factors and conditions will be analyzed.
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2 | TERMINOLOGY AND CLASSIFICATION
BASICS
A number of different terms related to PA have been examined in clin-
ical research relating to CV and non-CV outcomes (Table 1).2
Sedentarism refers to prolonged periods of minimal energy expendi-
ture associated with common practices such as television viewing and
time on the computer. PA is any leisure or occupational activity that is
accompanied by an increase in energy expenditure compared to the
resting state. Exercise is PA that is planned and structured with the
goal of promoting fitness and health. PA and exercise lead to improve-
ments in physical and cardiorespiratory fitness (CRF), an effect that is
also modulated by genetic factors.7
Classification of exercise is largely based on the principal form of
energy production, the extent of body movement, the participating
muscles, and the main benefitting component of physical fitness.6
Dynamic or isotonic exercise refers to the purposeful activity with
repetitive movement of large muscles groups and joints that leads to
substantial elevations in heart rate and expenditure of energy (eg, jog-
ging, skiing, bicycling, and swimming). Static or isometric exercise is
the contraction of muscles without movements of the joints. Resis-
tance (strength) exercise is performed against an opposing force in
order to improve muscular strength and/or endurance. It may be
dynamic with changes in the length and tension of muscles (eg,
weight-lifting, circuit training, and elastic resistance bands) or static
(eg, handgrip and plank position). Exercise sessions and their load are
defined by their duration, frequency, intensity, and weekly volume.
Intensity of exercise is traditionally defined by percentage of peak
heart rate or peak oxygen consumption. For ease of patient communi-
cation, mild activity would allow singing, moderate activity would
allow speaking, and vigorous activity would allow only a few words to
be exhaled (the so-called talk test). An exercise session is defined as
aerobic or anaerobic based on the availability of oxygen for produc-
tion of energy required for muscle contraction. Energy expenditure is
generally expressed as Metabolic Equivalent of Task (MET) where
1 MET is energy expenditure at rest and equates to a peak oxygen
consumption of 3.5 mL/min/kg. Energy expenditure of 3-5.9 MET
defines moderate-intensity exercise and of >6 METs defines vigorous
exercise. A proposed method to quantify aerobic exercise volume is
to calculate the MET score by multiplying the frequency and duration
per week of exercise by the intensity of exercise in MET. Current
guidelines recommend approximately 7.5 MET-hours/week of
exercise.8
The most studied training modality is continuous exercise train-
ing, characterized by predominantly dynamic, moderate-intensity
exercise at a constant workload for a prolonged period of time. This
modality has been shown to effectively improve maximum work
capacity and reduce mortality in health and CV disease. High-intensity
interval training (HIIT) has been derived from standard athletic training
programs and has emerged as one of the fastest growing exercise pro-
grams in recent years. A typical session consists of four to six
repeated, short (1-4 minutes) bouts of vigorous effort interspersed
TABLE 1 Terminology related to physical activity2,6
Term Definition Examples/components
Sedentary behavior Waking behavior with energy expenditure ≤1.5 metabolic equivalents of task
while in seated, reclined, or lying posture.
Television viewing, computer use,
video games, lying in bed,
sleeping, etc.
Physical activity Any bodily movement produced by the contraction of skeletal muscles, which
increases energy expenditure above the basal level of the resting state.
Household and occupational
activities; commuting;
gardening; dancing; exercise
and sports, etc.
Physical inactivity Physical activity levels less than those recommended for optimization of health
and prevention of premature disease and death.
-
Exercise A subset of physical activity that is repetitive, planned, structured, and often
goal-oriented, intending to promote physical fitness and health.
Aerobic and endurance exercise;
and resistance exercise.
Exercise training A subsidiary of exercise that denotes physical activity performed during leisure
time, targeting the improvement or maintaining of physical fitness and
performance.
-
Physical fitness An individual's attribute resulting from physical activity and exercise and
denoting the ability to carry out standard physical tasks without undue fatigue,
and sufficient energy to enjoy leisure-time activities and respond to
emergencies.
Muscular strength; power, and
endurance; cardiorespiratory
endurance and fitness;
flexibility; balance; speed of
movement; and reaction time.
Sports An activity involving physical exertion, coordination, and skill that is mastered
through planned and vigorous training and is performed for improvement in
physical fitness, entertainment or competition.
Power, endurance, skill, and
mixed.
Athlete An individual performing regular exercise training (for an arbitrarily defined
volume of at least 4 to 5 h a week) in one or more sports disciplines in order to
participate in competitive events at an amateur or professional level.
Power, endurance, skill, and
mixed.
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with brief periods (1-3 minutes) of active recovery of moderate
effort. High-IIT may be more effective compared to continuous
training in improving CRF, reducing weight and improving glycaemic
control but its long-term prognostic effect in CV disease needs fur-
ther study. Pyramid training, characterized by stepwise increase and
decrease of workload, is another interesting modality that may
improve physical fitness in the shortest time, but also warrants fur-
ther evaluation. Finally, resistance training is gaining ground as it
improves muscle strength and aerobic capacity, with the maximum
effect seen when it is combined with endurance exercise. Resistance
training is particularly important for improving muscle tone, bone
density, and coordination which become increasingly important with
senescence.
3 | PA AND OUTCOME BENEFITS
Forty years of thorough research has examined the epidemiological
effects of PA on CV prognosis and mortality. Unsurprisingly,
sedentarism/physical inactivity on one side and exercise/CRF on the
other exhibit opposite associations with CV outcomes, including heart
failure (HF) and CAD, and mortality (Table 2).9-13
TABLE 2 Representative studies published in the last 5 years examining associations of physical activity and fitness with mortality
Study N Design
Follow-up
(years) Participants
Assessment of
activity Main finding
Arem et al
(2015)9
661 137 Pooled analysis of six
prospective studies
14 Men and women
aged 21-98 y
Study-specific PA
questionnaires.
Compared to no leisure PA,
mortality risks were as follows:
<7.5 MET-h/week: HR, 0.80 (95%
CI, 0.78-0.82)
7.5-15 MET-h/week: HR, 0.69
(95% CI, 0.67-0.70)
15-22.5 MET-h/week: HR, 0.63
(95% CI, 0.62-0.65).
Lear et al
(2017)10
141 945 Multinational
prospective cohort
study
7 Individuals aged
35-70 y free of
CV disease
1-week total physical
activity assessed
using the long-form
International
Physical Activity
Questionnaire.
Compared to low PA (<150 min),
combined mortality and major
CV disease risks were as
follows:
150-750 min: HR, 0.85 (95% CI,
0.80-0.91)
>750 min: HR, 0.73 (95% CI,
0.68-0.77).
O'Donovan
et al (2017)11
63 591 Pooled analysis of 11
cohorts from
household-based
surveillance studies
18 Males and
females older
than 40 y
Self-reported PA. Compared with inactive
participants, all-cause mortality
risks were as follows:
Insufficiently active: HR, 0.66 (95%
CI, 0.62-0.72)
Regularly active: HR, 0.65 (95% CI,
0.58-0.73)
Weekend warriors: HR, 0.70 (95%
CI, 0.60-0.82).
Imboden MT
et al (2018)12
4137 Observational study
(BALL ST cohort)
24 Self-referred
apparently
healthy adults
(42.8 ± 12.2 y).
Measurement of peak
VO2 by
cardiopulmonary
exercise testing
using standardized
treadmill exercise
protocols.
Each single increase in METs was
associated with 11.6%, 16.1%,
and 14.0% reductions in
all-cause, CV, and cancer
mortality, respectively.
Clausen et al
(2018)13
5107 Observational study
(Copenhagen Male
study)
46 Middle-aged,
employed men
free of CV
disease
(40-59 y)
Calculation of peak
VO2 with Åstrand's
nomogram by using
a standard bicycle
ergometer test.
After multivariate adjustments,
compared to below normal CRF,
added years of life expectancy
were as follows:
Low normal CRF: 2.1 y (95% CI,
0.7-4.4; P = .002)
High normal CRF: 2.9 y (95% CI,
1.5-4.2; P < .001)
Above normal CRF: 4.9 y (95% CI,
3.1 to 6.7; P < .001).
Abbreviations: CRF, cardiorespiratory fitness; CV, cardiovascular disease; MET, metabolic equivalents; PA, physical activity.
KASIAKOGIAS AND SHARMA 3
3.1 | Sedentarism
A remarkably consistent association of sedentary behavior with all-
cause and CV mortality and CV disease has been documented. A
recent meta-analysis of 34 studies and over 1.3 million participants
revealed a nonlinear relationship between total sedentary behavior
and all-cause and CV mortality independent of PA.14 Television view-
ing time presented the strongest association. A threshold of 6 to
8 hours/day of total sitting time and 3 to 4 hours per day of TV view-
ing over which the risk increased was identified. The calculated risk
for each additional hour of TV viewing below and above 4 hours was
1.02 (0.99-1.04) and 1.08 (1.05-1.12), respectively. A linear dose-
response association of both average sedentary time and sedentary
bout duration was identified with the use of accelerometers in 5638
older women (mean age of 79 years) free of CV disease participating
in the Objective Physical Activity and Cardiovascular Health study.15
Women who were classified as having a high sedentary time and long
durations of sedentary bouts had a 34% greater risk for CV disease
(HR = 1.34; CI = 1.08-1.65) compared to the reference group.
It is clear that an individual may be physically active, perhaps even
following the current exercise recommendations, and still be seden-
tary for prolonged periods either at work or during leisure time. It has
been estimated that half of the time spent awake is characterized by
sedentary behavior. Recent data, however, suggest that concurrent
increasing levels of PA may positively alter the association of
sedentarism with a worse outcome. In a meta-analysis that stratified
patients by quartiles of PA, there was a dose-response association
between sitting time and CV mortality in the lowest PA quartile (9%-
32% higher risk), but this association was progressively ameliorated
and eventually disappeared across increasing levels of PA.16 Current
guidelines propose reducing the time spent sitting by introducing
periods of PA of any kind.17 For people incapable of indulging in regu-
lar PA, alternating sitting periods with periods of standing is an effi-
cient method for improving outcomes.18
3.2 | PA and exercise
PA and exercise are independently associated with lower CV morbid-
ity and CV and all-cause mortality in a dose-response manner. All
types of PA are efficient in preventing CV disease irrespective of gen-
der, age, and race and CV risk factors. Clinical guidelines of major soci-
eties recommend a minimum of 150 min/week of moderate intensity
(1000 kcal/week) or 75 min/week of vigorous intensity aerobic exer-
cise, with an optimal benefit in terms of longevity and protection from
CV events expected in three to five times as much for either.5,8,9
Little exercise is better than none and even simple standing
exhibits a dose-response relationship with lower rates of mortality.18
Similarly, moderate or vigorous exercise that is below the rec-
ommended volume by current guidelines is still associated with lower
rates of CV and all-cause mortality. There is a curvilinear relationship
between aerobic exercise volume and CV risk, where at the lower end
of PA levels even small increases lead to large reductions in risk, while
at the higher end there is a progressive decrease in the amount of
benefit achieved.9
Exercise inevitably improves CRF, which is optimally evaluated by
measurement of peak VO2 during cardiopulmonary exercise testing
but may also be assessed by exercise time, maximum power output
and other exams such as the 6-minute walk test. CRF is actually a
stronger predictor of outcome compared to PA or exercise training, as
evident in studies in healthy populations and populations with or at
risk of CV disease.19 A decrease in CV and all-cause mortality risk
ranging from 10% to 25% per 1 MET increase in exercise capacity has
been observed in healthy individuals, and those with multiple risk fac-
tors or established CV disease and independently of gender, age or
race.12,13,20 The association between CRF and mortality may be curvi-
linear, as is the case with exercise.
4 | RISK FACTORS
The beneficial effect of exercise on CV outcome is primarily through
modulation of standard CV risk factors for atherosclerosis including
hypertension (HTN), diabetes, dyslipidemia, and obesity.21 More than
two-thirds of the expected risk reduction related to exercise seems to
arise from improvements in these classic risk factors (Figure 1). In
addition, individuals who exercise regularly would be expected to be
leading a healthy lifestyle that includes abstaining from smoking. An
acute bout of exercise has been shown to effectively reduce the urge
of smoking in both men and women.22 The benefits of exercise on tra-
ditional CV risk factors are described below.
4.1 | Hypertension
The effectiveness of exercise in reducing BP is evident from the phe-
nomenon of acute postexercise hypotension that may last for up to
24 hours. In turn, chronic reduction in BP in response to exercise
training has been well-studied and attributed predominantly to
improvements in nitric oxide-mediated endothelial function and atten-
uations in systemic vascular resistance, and reduced activity of the
sympathetic nervous system and the renin-angiotensin-aldosterone
axis.23 An impressive number of large-scale epidemiological studies,
controlled clinical trials and subsequent meta-analyses have consis-
tently shown that regular aerobic exercise is accompanied by a BP-
lowering effect of 3 to 7 mmHg and potentially reaching 15 mmHg.23
The response of BP to exercise is greater with higher exercise vol-
umes and perhaps more intense exercise and is more pronounced in
those with a higher baseline BP. Indeed, the benefit of aerobic training
is more evident in hypertensive individuals, and rivals the antihyper-
tensive effects of commonly prescribed first-line drugs. Accordingly,
current relevant recommendations advise for an ideal of 300 minutes
of moderate or 150 minutes of vigorous activity per week for patients
with HTN or high normal BP.24 Twenty-four-hour BP evaluations in
hypertensive individuals reveal that aerobic training has a greater
impact on daytime rather than night time systolic BP.25 In patients
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with resistant HTN, an aerobic exercise program has been shown to
decrease ambulatory BP by 6/3 mmHg.26
Isometric and resistance exercise were previously approached
with skepticism in hypertensive patients due to fear of an exaggerated
BP response, increases in arterial stiffness and further deterioration of
HTN. In recent years, it has been shown that these are safe exercise
modalities for hypertensive patients that also lower BP but perhaps to
a lower extent compared to aerobic training. However, a meta-
analysis of 64 controlled studies of moderate-intensity dynamic resis-
tance training in patients with pre-HTN showed a BP-lowering effect
comparable to aerobic exercise, and also identified a dose-response
effect that was greater in individuals with a higher resting BP and in
populations who were not taking antihypertensive drugs.27 In another
large meta-analysis of 93 randomized controlled trials attempting a
head-to-head comparison of the effects of different types of exercise,
it was shown that endurance, dynamic resistance, and isometric resis-
tance training lower both systolic and diastolic BP, with the effect
being more evident for isometric exercise; however, the conclusions
were based on a relatively small number of studies including isometric
exercise.28 Resistance exercise is recommended two to three times
per week in the current HTN guidelines, but these recommendations
may be refined in the future with more accumulating evidence.24
Regular exercise is also effective in preventing HTN, with some
data supporting that higher exercise loads are associated with lower
rates of developing HTN. In a meta-analysis of 29 studies on over
3000 normotensives, it was shown that the risk of HTN decreased by
6% for every 10 METs of task hours/week increase in leisure-time
PA.29 In the same study a similar risk reduction was observed in indi-
viduals meeting the standard exercise recommendations compared to
inactive participants. Along these lines, a hypertensive BP response to
exercise has been associated with a higher risk of HTN, target organ
damage, and a worse CV outcome. Regular aerobic exercise and
increased fitness have been shown to ameliorate this phenomenon in
various populations including treated hypertensive patients.30
It is self-explanatory that the estimated BP-lowering effect of
exercise in patients with HTN is also associated with significant
improvements in CV outcomes. A decrease in BP of 6 to 7 mmHg
would translate to a CV risk reduction of up to 20% to 30%. Accord-
ingly, exercise capacity has been associated with lower mortality in
both prehypertensive and hypertensive individuals. Even among older
F IGURE 1 Cardiovascular effects of exercise. Regular exercise is accompanied by diverse beneficial effects in virtually all pathways
associated with atherosclerosis and cardiovascular diseases. Reduction in primary and secondary cardiovascular risk is achieved primarily by
improvements in classic risk factors, but also through alternate mechanisms such as autonomic modulation and anti-inflammatory protection
KASIAKOGIAS AND SHARMA 5
hypertensive individuals, every 1-MET increase in exercise capacity is
associated with an 11% lower risk of death.31
4.2 | Lipid metabolism
Aerobic exercise has been associated with a beneficial effect on lipo-
protein levels in both normolipidemic and hyperlipidemic individuals,
even though the overall effect is small and concurrent weight loss
may have contributed in the positive findings of some of the relevant
studies. Beneficial effects have been noted mostly for high-density
lipoprotein-cholesterol (HDL-C) levels but also for low-density
lipoprotein-cholesterol (LDL-C) particle size and apolipoprotein B and
triglyceride levels.32 The combination of exercise with dietary changes
provides greater reductions in LDL-C compared to either measure
alone. Exercise volume rather than intensity seem to be better associ-
ated with lipid changes. It has been estimated that the minimal exer-
cise volume in order to increase HDL-C level is 900 kcal of energy
expenditure or 120 minutes of exercise per week.33 The Studies of
Targeted Risk Reduction Interventions through Defined Exercise
(STRRIDE) was a randomized controlled study that examined the
effects of 7 months of two different volumes and intensities of aero-
bic exercise on risk factors in overweight and obese individuals with
mild and moderate dyslipidaemia.34 All exercise programs showed evi-
dence of beneficial changes in the lipoprotein profile. The high-
volume high-intensity group showed the greatest decreases in small
LDL-C without affecting the total LDL-C concentration. The same
amount of exercise led to increases in HDL-C cholesterol as well as in
decreases in triglycerides. In terms of outcome, among dyslipidaemic
individuals with a mean age of 58 years, statin treatment and
increased physical fitness have been independently associated with
lower mortality, while combined statin treatment and high fitness
levels were associated with a better prognosis compared to either
intervention alone.35
4.3 | Insulin sensitivity and diabetes mellitus
Regular leisure-time activity of different intensities has been associ-
ated with a 25% to 40% reduction in the risk of T2DM.17 Similarly,
each 1 MET higher CRF has been associated with an 8% lower risk
of T2DM.36 Habitual PA has been consistently associated with
improved insulin sensitivity and responsiveness, improved lipid pro-
files and BP levels as well as decreases in glycated hemoglobin
(HbA1c) by 0.5% to 0.7% in prediabetic and diabetic patients. A
meta-analysis of 56 studies on such patients showed that an
increase of 100 minutes in PA per week was associated with an
average decrease in fasting glucose by 4.71 mg/dL and in HbA1c by
0.16%.37 An analysis of the Health Benefits of Aerobic and Resis-
tance Training in Individuals With Type 2 Diabetes trial showed that
even patients with no change in their CRF after 9 months of exercise
revealed significant improvements in metabolic parameters including
decreases in HbA1c.38 Similarly, in patients with the metabolic
syndrome, aerobic exercise is accompanied by improvements in all
of its components, including body mass and waist circumference, BP,
and lipid profile.39 Taking just 5-minute breaks of prolonged sitting
by standing or walking is an effective way to elicit metabolic benefits
in populations at high risk of diabetes. For this reason, The American
Diabetes Association recommends that sedentary behavior should
be interrupted by periods of light intensity PA.17
A single session of low intensity exercise leads to acute improve-
ments in insulin sensitivity and uptake of fatty acids from skeletal
muscles. However, the benefits are more substantial with longer
periods and more intense bouts of exercise. An earlier meta-analysis
has shown that a 20-week program of moderate-intensity aerobic
exercise improves CRF and glycated hemoglobin (HbA1c), the latter
decreasing in parallel with more intense exercise.40 Resistance training
has also been shown to decrease HbA1c, increase lean body mass and
improve the response to the glucose tolerance test. A meta-analysis
of 14 trials in a total of 915 patients with T2DM that examined the
effects of aerobic, resistance and combined training documented an
overall better response of HbA1c, fasting glucose, and triacylglycerols
to combined training compared to the other modalities alone.41 Cur-
rent guidelines thus recommend that adults with T2DM should follow
an exercise training program that includes both aerobic and resistance
exercises to improve insulin metabolism and reduce all-cause and CV
mortality.17
4.4 | Obesity
Regular PA protects against weight gain throughout life, maintains
long-term weight loss and preserves lean body mass during caloric
restriction.42 Long-term exercise also seems to result in larger reduc-
tions in predominantly abdominal fat.43 Nevertheless, meta-analyses
that have examined the effects of exercise on weight loss have shown
that both high or low intensity exercise were associated with only
modest reductions in weight (by about 1.5 Kgr).44 Even when added
to caloric restriction the additional effect of exercise on weight loss
remains limited. Of note, it has been shown that CRF modulates the
association of weight with mortality, and obese but fit individuals
exhibit similar survival to individuals with normal weight.45
5 | CV CONDITIONS AND SECONDARY
PREVENTION
In the setting of secondary prevention, multiple studies have shown
that PA and exercise as well as CRF reduce the risk of new CV events.
Exercise may be performed at home, in community facilities or, ideally,
in the context of a cardiac rehabilitation program.5 The latter provides
the foundations for structured exercise prescription combined with
lifestyle advice and psychosocial support. Resistance exercise should
be included in the training routine in order to maintain muscle mass
and strength, further reduce body fat, increase CRF and improve qual-
ity of life.46
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5.1 | Coronary artery disease
Lack of PA is an independent predictor for CAD development. In a
case control study evaluating multiple CV risk factors for acute myo-
cardial infarction (MI) across 52 countries, regular exercise was associ-
ated with a 14% lower risk of MI among men and women of all age
groups and ethnicities.47 Conversely, lack of PA accounted for 12% of
the population-attributable risk of an acute event. More recently, in a
meta-analysis of 33 studies, a dose-response relationship of PA and
CAD was noted; a 20% risk reduction in individuals engaging in
300 minutes per week of moderate-intensity activity was
documented.48
A number of benefits of exercise in patients with established
CAD have been observed. Regular exercise contributes to greater
functional capacity and higher thresholds of angina presentation. At
the myocardial level, the effects of exercise may include retardation
of disease progression and regression of coronary plaques, improve-
ments in endothelial function, favorable mechanisms for healing endo-
thelial damage, coronary collateralization, and a positive effect on left
ventricular function and remodeling.49 Following MI, exercise training
exerts the greatest benefits on ejection fraction and left ventricular
volumes when started as early as 1 week after the acute episode and
lasting longer than 3 months.50
With respect to hard endpoints, there is consistent evidence that
exercise in the context of cardiac rehabilitation programs is associated
with lower CV mortality in patients after MI or after coronary
revascularisation. In a large meta-analysis of 63 studies examining var-
iable intensities and periods of aerobic exercise as part of cardiac
rehabilitation in patients post-MI or revascularization, a 26% reduc-
tion in CV death and an 18% reduction in hospital admissions was
documented.51 In contrast, data on such benefits in patients with sta-
ble CAD are limited by the small number of studies and small number
of participants and a review of 7 studies and 581 patients with stable
CAD failed to show an additional benefit of exercise-based cardiac
rehabilitation regarding mortality, acute events, or hospitalisations.52
Interestingly, some data have shown that in patients with CAD, high
levels of PA may be harmful. An analysis of patients with stable CAD
after an acute event or revascularisation procedure documented a
reverse J-shaped association of PA with CV mortality over a 10-year
period.53 Patients who performed 5 times the exercise recommenda-
tions showed more than a double risk of CV mortality compared to
those active two to four times per week. Therefore, individuals with
CAD who aspire to perform high-volume or intensity of exercise
should be evaluated thoroughly to exclude inducible myocardial
ischaemia, left ventricular dysfunction, and exercise related
arrhythmias.54
5.2 | Heart failure
Historically, exercise was prohibited in patients with HF due to fear of
haemodynamic compromise. Since the 1980's, a large set of evidence
has been accumulated that supports exercise as a strong preventive,
prognostic, and therapeutic modality in HF both in the setting of pri-
mary and secondary prevention. PA is associated with a lower risk of
HF across a wide range of body weights and independently of com-
orbidities.55 A large meta-analysis of 12 prospective studies confirmed
an inverse, linear, dose-response relationship between PA and risk of
HF. PA as per current guidelines (150 minutes of moderate-intensity
exercise per week) was associated with a 10% lower risk of HF com-
pared to no activity, while exercise levels double and quadriple of the
guidelines were associated with a 19% and 35% lower risk, respec-
tively.56 Similarly, a number of studies in different populations has
shown that for each added MET of greater CRF there is an approxi-
mately 20% lower risk of future HF.57 A report of the Coronary Artery
Risk Development in Young Adults study showed that lower CRF at a
young age is associated with abnormal remodeling of the left ventricle
and subclinical systolic and diastolic abnormalities in middle age.58
Recent evidence suggest that the protective effect of exercise and
CRF may be greater for HF with preserved ejection fraction (HFpEF)
than HF with reduced EF (HFrEF). A report from data derived from
three cohort studies documented a dose-response association
between leisure-time PA and HFpEF but not HFrEF.59
In patients with established HF, the lack of PA has been shown to
be accompanied by a doubling of risk of all-cause and CV mortality.60
Exercise intolerance and low CRF affect both quality of life and overall
prognosis in these patients, particularly in the elderly, where frailty
and cardiac and noncardiac comorbidities are much higher. In cases
with HFrEF, exercise also improves resting ventricular volumes, peak
exercise cardiac output and cardiac reserve, peak oxygen consump-
tion, and the lactate threshold.61 Indeed, exercise in patients with
either HFrEF or HFpEF improves peak VO2 by approximately 3 mL/Kg
or, in other words, by 15% to 17%, that would translate in a mortality
reduction of approximately 30%.62 In the very heterogenous popula-
tion with HFpEF, things are less clear, as, for instance, it is well-
established that long-term exercise may protect from the age-related
stiffening but not the impairment of ventricular relaxation.63 How-
ever, the role of diastolic dysfunction in the response of HFpEF
patients to exercise training remains to be elucidated.
Most early studies of exercise in HF were small and single-
centered and were based on continuous moderate-intensity aerobic
training. Altogether, they have provided promising evidence that exer-
cise training is accompanied by improvements in quality of life and
decreases in the risk of hospitalisations and long-term mortality. An
earlier meta-analysis of the ExTraMATCH Collaborative has shown
that exercise training for at least 8 weeks reduces mortality by 45% in
patients with HFrEF.64 The more recent HF: A Controlled Trial Inves-
tigating Outcomes of Exercise Training trial is the largest and most
cited randomized controlled trial in the field and examined the clinical
benefit of a supervised followed by an at-home aerobic training regi-
men on top of standard optimal therapy in patients with HFrEF of
New York Heart Association class II to IV and mean age of 59 years.65
This landmark study was plagued by low (30%) patient adherence but
did document a mildly significant decrease in the risk of CV mortality
and HF hospitalization by 15%, observable after prespecified adjust-
ment for major prognosticators. Accordingly, an updated meta-
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analysis by the Cochrane Collaboration Group reported that cardiac
rehabilitation in HF patients decreases hospitalisations in the short-
term 12 months) and may improve all-cause mortality in the long
term.66 Cardiorespiratory exercise training is recommended by all
major HF guidelines and it is promising that the number of countries
offering dedicated exercise training programs for these patients is
increasing.67
5.3 | Atrial fibrillation
A number of studies have shown that regular PA and satisfactory CRF
are associated with a lower incidence of atrial fibrillation (AF), a finding
at least partially mediated by concurrent improvements in established
risk factors for AF such as HTN and obesity. In numbers, moderate PA
in individuals aged more than 65 years reduces the risk of AF by
44%.68 The protective effect of exercise for AF may disappear and
actually reverse with long-term, high-volume endurance training. Atrial
dilatation, pulmonary vein stretch and induction of profibrotic pathways
have been suggested as potential mechanisms for this observation. Of
note, atrial enlargement with normal or supranormal atrial mechanics is
considered to be a feature of the athlete's heart that results from
increased cardiac output and volume overload and is not associated
with a higher prevalence of supraventricular arrhythmias.69
In patients with AF, exercise is safe, as long as sufficient rate control
has been achieved, and it has been shown to improve AF-related symp-
toms, exercise tolerance, and quality of life. Exercise may also have a
favorable effect on AF burden and AF recurrence, while more study data
are needed regarding the optimal training regimen as well as the effects
on hard endpoints in these patients.70 More recently, in a randomized
controlled trial in patients with either paroxysmal or persistent AF,
12 weeks of aerobic HIIT was associated with significant improvements
in time in AF, exercise capacity and left atrial and ventricular function.71
6 | CAN TOO MUCH EXERCISE HARM THE
HEART?
There are emerging studies reporting a J-shaped relationship between
exercise dose and CV morbidity and mortality. Some studies have also
shown there are diminishing returns beyond an exercise capacity of
12 METs.72,73 Small studies in lifelong endurance athletes have rev-
ealed evidence of coronary artery calcification (CAC) in almost 1 in
5 master male athletes and myocardial fibrosis in approximately 1 in
10 master male athletes.74 Coupled with an increased prevalence of
AF, there is a possibility that the stresses of lifelong intensive exercise
may have a potentially deleterious effect in some individuals with a
previously normal heart in male athletes, as the same has not been
reported in master female athletes. Short- and medium-term studies
have failed to show any association with increased CAC and CV mor-
tality but larger prospective studies are required to understand why
one man's high may represent another man's poison.75
7 | CONCLUSIONS
The strong assets of regular moderate exercise are its free availability
at low cost and its simultaneous benefits for preventing and improving
several cardiac diseases. Integration of exercise in the daily routine of
all individuals is essential to improve global health. It is important to
emphasize that current evidence suggest that exercising for three to
five times the current recommendations is the ideal dose for maxi-
mum benefit to prevent several CV diseases, although even 1 hour
per week of exercise is associated with a health benefit. Some individ-
uals engaging in lifelong endurance exercise show a high prevalence
of CAC, myocardial fibrosis and AF, the long-term significance of
which is uncertain. Overall regular exercise is associated with a signifi-
cant reduction in CV morbidity and mortality and longevity of an addi-
tional 2 to 7 years of life.
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